Piperazine-substituted benzothiophenes for treatment of mental disorders

A technology of substituents and representatives, applied in the field of new heterocyclic compounds, can solve problems such as not explicitly disclosing compounds

Active Publication Date: 2008-04-02
OTSUKA PHARM CO LTD
View PDF2 Cites 73 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0010] However, WO2005 / 019215 A1 does not explicitly disclose the compounds of the present invention

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Piperazine-substituted benzothiophenes for treatment of mental disorders
  • Piperazine-substituted benzothiophenes for treatment of mental disorders
  • Piperazine-substituted benzothiophenes for treatment of mental disorders

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0358] Preparation of 7-[4-(4-benzo[b]thiophen-4-yl-piperazin-1-yl)butoxy]-1H-quinolin-2-one

[0359] 9.0g 7-(4-chlorobutoxy)-1H-quinolin-2-one, 10g 1-benzo[b]thiophen-4-yl-piperazine hydrochloride, 14g potassium carbonate, 6g sodium iodide and 90 ml of dimethylformamide were stirred at 80°C for 2 hours. Water was added to the reaction solution, and the precipitated crystals were separated by filtration. The crystals were dissolved in a mixed solvent of dichloromethane and methanol, dried over magnesium sulfate, and the solvent was evaporated under reduced pressure. The residue was purified by silica gel column chromatography (dichloromethane:methanol=100:3). Recrystallization in ethanol prepared 13.6 g of 7-[4-(4-benzo[b]thiophen-4-yl-piperazin-1-yl)butoxy]-1H-quinoline-2 in the form of a white powder -ketone.

[0360] The melting point is 183.5-184.5°C

[0361] 1 H-NMR (DMSO-d 6 )δppm:

[0362] 1.6-1.75(2H, m), 1.75-1.9(2H, m), 2.44(2H, t, J=7Hz), 2.5-2.8(4H, m), 2.9...

Embodiment 2

[0364] Preparation of 3-[2-(4-benzo[b]thiophen-4-yl-piperazin-1-yl)ethoxy]-1H-quinolin-2-one

[0365] Using a method similar to that in Example 1, 3-[2-(4-benzo[b]thiophen-4-yl- piperazin-1-yl)ethoxy]-1H-quinolin-2-one.

[0366] white powder (chloroform)

[0367] The melting point is 201.9-204.5°C

[0368] 1 H-NMR (CDCl 3 )δppm:

[0369] 2.90-2.95(4H, m), 3.10(2H, t, J=5.9Hz), 3.23-3.27(4H, m), 4.30(2H, t, J=5.9Hz), 6.9O(1H, d, J =7.7Hz), 7.08(1H, s), 7.15-7.32(2H, m), 7.37-7.41(4H, m), 7.47-7.49(1H, m), 7.55(1H, d, J=8.1Hz) , 11.33(1H,br).

Embodiment 3

[0371] Preparation of 7-[3-(4-benzo[b]thiophen-4-yl-piperazin-1-yl)propoxy]-4-methyl-1H-quinolin-2-one

[0372] Using a method similar to that in Example 1, 7-[3-(4-benzo[b]thiophene was prepared from 7-(3-chloropropoxy)-4-methyl-1H-quinolin-2-one -4-yl-piperazin-1-yl)propoxy]-4-methyl-1H-quinolin-2-one.

[0373] Light brown powder (ethyl acetate)

[0374] The melting point is 202-208°C

[0375] 1 H-NMR (DMSO-d 6 )δppm:

[0376] 1.95-2.0(2H, m), 2.37(3H, s), 2.55(2H, t, J=7Hz), 2.6-2.7(4H, m), 3.05-3.2(4H, m), 4.09(2H, t , J=6.5Hz), 6.21(1H, bs), 6.8-6.85(2H, m), 6.90(1H, d, J=7.5Hz), 7.28(1H, dd, J=8Hz, 8Hz), 7.41( 1H, d, J=5.5Hz), 7.6-7.7(2H, m), 7.69(1H, d, J=5.5Hz), 11.41(1H, bs).

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
melting pointaaaaaaaaaa
melting pointaaaaaaaaaa
melting pointaaaaaaaaaa
Login to view more

Abstract

The present invention provides a heterocyclic compound represented by the general formula (1): The compound of the present invention has a wide treatment spectrum for mental disorders including central nervous system disorders, no side effects and high safety.

Description

technical field [0001] The present invention relates to a novel heterocyclic compound. Background technique [0002] Due to the different causes of schizophrenia and bipolar disorder, mood disorders and affective disorders, there is a need for a drug with multiple pharmacological effects in order to expand the therapeutic spectrum. [0003] A kind of quinolone derivative disclosed in WO2004 / 026864A1, its general formula is: [0004] [0005] (Wherein, A' represents -(CH 2 ) m CH 2 -, -(CH 2 ) m O- etc.; m represents an integer from 1 to 4; and R 4 C representing a hydrogen atom, which may be substituted by 1 to 3 fluorine atoms 1-4 alkyl, etc.). The derivative has D 2 Receptor antagonist activity and serotonin 2A (5-HT 2A ) receptor antagonist activity for the treatment of schizophrenia and other central nervous system diseases). [0006] However, it is not stated in WO2004 / 026864A1: the quinolone derivatives described in the document also have D 2 Receptor pa...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): C07D409/12A61K31/435A61P25/00
CPCC07D409/12C07D409/14C07D405/12A61K31/496A61P25/00A61P25/14A61P25/16A61P25/18A61P25/22A61P25/24A61P25/28A61P25/32A61K9/2054A61K9/2059C07D409/04
Inventor 山下博司松原淳大岛邦生黑田英明伊藤展明宫村伸清水聪田中达义高桥永
Owner OTSUKA PHARM CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap